InvestorsHub Logo
Followers 185
Posts 2462
Boards Moderated 0
Alias Born 02/10/2017

Re: None

Thursday, 01/14/2021 9:14:11 PM

Thursday, January 14, 2021 9:14:11 PM

Post# of 238
Great news we just got 28 million from Canter Fitzgerald.

broke a 52 week high and multi year today!!

EVGN gets the upper hand here can sell when they want too this reminds me of another company that I invested in recently & then the share price flew 175%+. a few weeks later.

this company now has plenty of cash & no debt.

I just bought another 5k shares after hours under $6.00

will buy 10-20k more shares tomorrow in increments between $6.00-$7.00 before it blast off into double digits and beyond.

Cathie Wood ARKG ETF & Cantor Fitzgerald owns EVGN and expects exponential growth and scaling on multiple fronts from this cutting edge gene editing AI technology protocol.

EVGN Subsidiaries:
Evogene group supports independent entities focusing on a defined commercial field with an exclusive license to use our unique solution for product development.

4.Lavie Bio

Evogene to Participate in CRISPR-IL Consortium to Provide End-to-End Artificial Intelligence System for Genome-Editing.

Genome Stocks-Gene Editing.
$PACB 6.2 billion market cap
$BEAM 5.4 billion market cap
$CRSP 13 billion market cap
$EDIT 4.8 billion market cap
$SGMO 2.3 billion market cap
$NTLA 4.8 billion market cap
$BLUE 3.3 billion market cap
$BNGO 1.2 billion market cap
$EVGN 200 million market cap 35 million shares 45% owned by institutions & insiders.

Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVGN News